Work

A phase I trial of the combination of erlotinib and tipifarnib in patients with advanced solid tumors

Year: 2005

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2005.23.16_suppl.3000

Authors: C. X. Ma, G. Croghan, J. Reid, L. Hanson, S. Mandrekar, R. Marks, A. Adjei, A. Furth

Institution: Mayo Clinic

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590188240

Cites:

Cited by: 10

Related to: 10